Enliven is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics to help people not only live longer, but live better. Enliven aims to ...

The posters can be accessed through the "News & Publications" tab on the MOMA Therapeutics website at the time of each presentation’s starting session. MOMA Therapeutics is a clinical-stage ...

Annual Meeting being held from April 25-30, 2025, in Chicago, IL. Title: AI-powered approaches accurately predict t(11;14) positive multiple myeloma from H&E-stained histologic sections by identifying ...

Akebia-supported posters will be displayed at NKF SCM25 during Exhibit Hall hours. Cardiovascular Risk in Patients With DD-CKD Randomized to Vadadustat vs Darbepoetin Alfa With or Without ...

For more and to view the abstract, visit the AACR Annual Meeting website. As previously announced, on December 11, 2024, TuHURA entered into a definitive agreement with Kineta, Inc. (OTC Pink ...

today announced upcoming poster presentations including one for CM24 in the treatment of pancreatic cancer, and two for NT219 in the treatment of colorectal and head and neck cancers, at the 2025 ...

You do not need to pay membership dues to create an ESA member account or submit for the meeting. We invite submission of abstracts for latebreaking and project proposed posters for the 2025 ESA ...

today announced upcoming poster presentations including one for CM24 in the treatment of pancreatic cancer, and two for NT219 in the treatment of colorectal and head and neck cancers, at the 2025 ...

Annual Meeting being held April 25-28, 2025 in Los Angeles, California. These presentations will showcase the company’s latest clinical advancements and novel research in laser scleral ...

today announced a poster regarding the Company’s clinical asset, CT-95, a mesothelin (“MSLN”) x CD3 TCE will be presented at the American Association for Cancer Research (AACR) Annual ...